AngioDynamics, Inc.

This stock has a reasonable momentum. AngioDynamics, Inc. is a mediocre stock to choose.

AngioDynamics, Inc. engages in the development, manufacture, and sale of medical devices for vascula...

News

AngioDynamics announces CE Mark approval in Europe for Auryon System

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

AngioDynamics Announces CE Mark Approval in Europe for the Auryon System

Business Wire AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the bodys vascular system, expanding cancer treatment options...\n more…

AngioDynamics (NASDAQ:ANGO) & NovoCure (NASDAQ:NVCR) Financial Contrast

Zolmax AngioDynamics (NASDAQ:ANGO - Get Free Report) and NovoCure (NASDAQ:NVCR - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses...\n more…

AngioDynamics (ANGO) Upgraded to Strong Buy: Here's Why

Zacks Investment Research AngioDynamics (ANGO) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates...\n more…

AngioDynamics (NASDAQ:ANGO) and NovoCure (NASDAQ:NVCR) Head to Head Review

Ticker Report NovoCure (NASDAQ:NVCR - Get Free Report) and AngioDynamics (NASDAQ:ANGO - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies...\n more…

AngioDynamics, Inc. (NASDAQ:ANGO) Shares Acquired by Price T Rowe Associates Inc. MD

Ticker Report Price T Rowe Associates Inc. MD increased its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 9.1% during the first quarter, HoldingsChannel.com reports. The fund owned...\n more…